Companies / Astria Therapeutics, Inc.

Astria Therapeutics, Inc.

ATXSCIK 1454789BOSTON, MAcatabasis.com

Financials · FY2017

Revenue$500.0K
Net income$-94.26M
Total debt$833.0K
Cash$96.28M
Diluted EPS$-1.68
Shares outstanding57.1M

Ownership

57.1M shares outstanding · as of Oct 31, 2025
6.6%10%+ / strategic
Ownership
10%+ / strategic6.62%3,776,154
Public float93.38%53,308,684

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Komjathy AndrewChief Commercial Officer
0.00%0
Milne Jill C.CEOCEO and President · Director
0.00%0
0.00%0
Bate KennethDirector
Callori FredDirector
Clauser NoahChief Financial Officer
Cole Hugh MDirector
Harshbarger BenjaminChief Legal Officer

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 23, 2026Callori Fred
Director
OtherStock Option (Right to Buy)-27K
-100.00%
0
0.00% of shares
low
Jan 23, 2026Callori Fred
Director
OtherStock Option (Right to Buy)-14K
-100.00%
0
0.00% of shares
low
Jan 23, 2026Callori Fred
Director
OtherStock Option (Right to Buy)-14K
-100.00%
0
0.00% of shares
low
Jan 23, 2026Callori Fred
Director
OtherStock Option (Right to Buy)-8K
-100.00%
0
0.00% of shares
low
Jan 23, 2026Callori Fred
Director
OtherStock Option (Right to Buy)-14K
-100.00%
0
0.00% of shares
low
Jan 23, 2026Clauser Noah
Executive
OtherStock Option (Right to Buy)-263K
-100.00%
0
0.00% of shares
low
Jan 23, 2026Clauser Noah
Executive
OtherStock Option (Right to Buy)-55K
-100.00%
0
0.00% of shares
low
Jan 23, 2026Komjathy Andrew
Executive
OtherStock Option (Right to Buy)-225K
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Glazer Capital, LLCPassive13G/A3,776,154
Vestal Point Capital, LPPassive13G/A